Viral Hepatitis

Overview

4.6 out of 5 (136 Reviews)

Credits

2.00

Post Assessment Questions

16

Start Date

1 Sep 2023

Last Review Date

10 Mar 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

120 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Hepatitis is defined as inflammation of the liver that can result from a variety of causes, such as heavy alcohol use, autoimmune disorders, drugs, or toxins. However, the most frequent cause of hepatitis is due to a viral infection, referred to as "viral hepatitis." Several different strains of viruses can cause hepatitis. In the United States, the most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C. The other types of viral hepatitis are hepatitis D and E, which are encountered less frequently.

The severity and duration of the hepatitis are variable depending on the pathogen and comorbidities. Based on the etiology of hepatitis, the severity can range from mild, nearly asymptomatic, to severe illness requiring liver transplantation. Hepatitis can be further classified into "acute" and "chronic" based on the duration of the inflammation in the liver. Depending on the type, hepatitis can be self-limited and resolve quickly, while others can become more chronic and last years. Some individuals may rapidly progress to fulminant liver failure, while others may be asymptomatic carriers.

This activity reviews the causes of viral hepatitis, its epidemiology, symptomatology, patient evaluation, treatment, prognosis, and preventive strategies. It also highlights the role and importance of a multidisciplinary healthcare team in caring for patients with viral hepatitis.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Differentiate the etiology, epidemiology, and pathophysiology of the various types of viral hepatitis.

  • Implement evidence-based treatment and preventive strategies for viral hepatitis.

  • Identify common complications of viral hepatitis. 

  • Apply effective interprofessional team strategies for improving care coordination and communication to advance and improve outcomes for patients with viral hepatitis.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurses: StatPearls designates this activity for 2.00 ANCC contact hour(s). Nurses should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Keren P. on 12/31/2021

Claire H. on 10/17/2021

Sarah A. on 11/16/2021

Anne W. on 12/9/2021

Terri C. on 12/24/2021

Bhupendra G. on 3/14/2022

Jennifer W. on 7/1/2022

Amanda B. on 7/26/2022

Katrina S. on 7/27/2022

Kennon M. on 7/27/2022

Madison T. on 7/27/2022

Justin L. on 7/28/2022

Thank you very much

Yassine Hafnawi N. on 7/28/2022

Treasa G. on 7/28/2022

Angela F. on 7/28/2022

christina K. on 7/29/2022

Alexei K. on 7/29/2022

Angela R. on 7/30/2022

Kerry E. on 7/30/2022

Yuliya N. on 7/30/2022

Erica M. on 7/31/2022

Andre D. on 7/31/2022

Eric C. on 7/31/2022

In chronic hepatitis patients, vitamin therapy is often necessary , like vitamin B12. When simultaneous of chronic hepatitis C and Biermer's disease, is it safe to administer Vitamin B12 ?, since non-Hodgkin lymphoma can be a complication of Chronic hepatitis ?

Dung N. on 8/4/2022

Patrice F. on 8/1/2022

Shannon B. on 8/2/2022

Patricia G. on 8/2/2022

April M. on 8/2/2022

Lauren E. on 8/3/2022

Rebecca H. on 8/4/2022

Asta B. on 8/6/2022

Christina M. on 8/6/2022

Said A. on 8/6/2022

kim r. on 8/7/2022

jennifer S. on 8/7/2022

Ava C. on 8/8/2022

Namariq I. on 8/10/2022

Jiewen Z. on 8/8/2022

Jodi F. on 8/8/2022

Parisa S. on 8/8/2022

none

Raul M. on 8/10/2022

BERND D. on 8/8/2022

Alyssa R. on 8/8/2022

Jessica S. on 8/8/2022

Very ambitious to cover such a broad topic. Good effort. But too superficial given the breadth of the topic.

Huey Li C. on 8/8/2022

Nahla K. on 8/9/2022

Leon K. on 8/9/2022

Nancy A. on 8/9/2022

L. Michelle S. on 8/9/2022

Marylou D. on 8/9/2022

Cheryl S. on 8/10/2022

CHERYL B. on 8/11/2022

Dana S. on 8/11/2022

naru g. on 8/12/2022

Tara C. on 8/11/2022

ALVA M. on 8/12/2022

Allen Kwok Lun L. on 8/13/2022

massoud r. on 8/14/2022

Cheryl C. on 8/14/2022

Felicia H. on 8/14/2022

Lameta M. on 8/14/2022

Maria C. on 8/14/2022

Gerlande P. on 8/15/2022

mangilal l. on 8/16/2022

Jeromy P. on 8/18/2022

Shelley B. on 8/17/2022

Thykle C. on 8/16/2022

Kristie V. on 8/16/2022

Than you

Ruzanna S. on 8/18/2022

Srinivasarao C. on 8/18/2022

Holly C. on 8/18/2022

Talia F. on 8/18/2022

April F. on 8/18/2022

Taylor M. on 8/19/2022

Nicole F. on 8/20/2022

Mohammed A. on 8/20/2022

Susan G. on 8/20/2022

RAJ K. on 8/20/2022

Heidi B. on 8/20/2022

Alyssa G. on 8/22/2022

Jeanine A. on 8/21/2022

Kristie G. on 8/22/2022

Adam G. on 8/22/2022

hazel r. on 8/22/2022

Eric C. on 8/23/2022

Lhoryfel V. on 8/23/2022

alice v. on 8/24/2022

none

Mary B. on 8/25/2022

Donna C. on 8/25/2022

Excellent program

Lex H. on 8/25/2022

Regina P. on 8/26/2022

Audrey A. on 10/11/2022

Mary Y. on 11/10/2022

Theodore B. on 11/20/2022

Anna L. on 12/26/2022

Wr1wr2wr3wr4wr5?

Daniela E. on 5/12/2023

Manreet K. on 5/15/2023

Ron H. on 5/17/2023

Jana T. on 6/1/2023

Leon B. on 6/8/2023

Lily L. on 7/4/2023

Michele N. on 7/17/2023

Christine G. on 7/21/2023

Michael B. on 7/27/2023

Mergene T. on 8/1/2023

Susan S. on 8/18/2023

Ashley N. on 10/3/2023

Marcelo on 10/4/2023

Christina S. on 10/30/2023

Kayci H. on 10/30/2023

Amina O. on 11/8/2023

Darren S. on 11/11/2023

Alice F. on 11/21/2023

Ann R. on 11/25/2023

Abigail S. on 12/6/2023

Stephanie N. on 12/31/2023

Paul P. on 12/31/2023

Ashraf E. on 1/30/2024

William S. on 1/30/2024

robert c. on 2/1/2024

Isabel R. on 2/3/2024

Erica G. on 2/9/2024

Alice F. on 2/11/2024

Stacy W. on 2/19/2024

Gurinder S. on 2/19/2024

Interferon is not used to treat hepatitis C anymore. The review dwells a lot on interferon and too little on DAA. I recommend improving this.

Klaus M. on 2/28/2024

camille j. on 3/11/2024

Jade L. on 3/8/2024

Helean Z. on 3/9/2024

Alan S. on 3/10/2024

Fahad A. on 3/15/2024

Kelly T. on 3/17/2024

Kashif K. on 3/23/2024

Mary Y. on 4/10/2024

ISLAM A. on 4/13/2024

Robert S. on 4/16/2024

Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6674 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7926.5 hours of CE.

Single Activity

Take this single activity

$50 1 activity

6 Month Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$199 per 1 year per user